Skip to main content

Table 3 Trial characteristics-continued

From: Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database

 

All

BF

OT

Availability*

(n = 245, 100 %)

(n = 147, 60 %)b

(n = 98, 40 %)c

BF vs OT**

Primary purpose

    

 Data not availablea

7 (2.9 %)

4 (2.7 %)

3 (3.1 %)

1.000*

Treatment

214 (89.9 %)

126 (88.1 %)

88 (92.6 %)

0.550**

Supportive Care

8 (3.4 %)

6 (4.2 %)

2 (2.1 %)

Diagnostic

9 (3.8 %)

6 (4.2 %)

3 (3.2 %)

Health Services Res.

3 (1.3 %)

3 (2.1 %)

0 (0 %)

Prevention

4 (1.7 %)

2 (1.4 %)

2 (2.1 %

Masking

    

 Data not availablea

37 (15.1 %)

19 (12.9 %)

18 (18.4 %)

0.244*

Open Label

195 (93.8 %)

117 (91.4 %)

78 (97.5 %)

0.105**

Double-Blind

6 (2.9 %)

4 (3.1 %)

2 (2.5 %)

Single Blind

7 (3.4 %)

7 (5.5 %)

0 (0 %)

Allocation

    

 Data not availablea

111 (45.3 %)

65 (44.2 %)

46 (46.9 %)

0.675*

Non-Randomized

44 (32.8 %)

31 (37.8 %)

13 (25.0 %)

0.124**

Randomized

90 (67.2 %)

51 (62.2 %)

39 (75.0 %)

Overall

    

Active, not recruiting

52 (21.2 %)

34 (23.1 %)

18 (18.4 %)

0.075**

Completed

83 (33.9 %)

40 (27.2 %)

43 (43.9 %)

Recruiting

96 (39.2 %)

62 (42.2 %)

34 (34.7 %)

Not yet recruiting

13 (5.3 %)

10 (6.8 %)

3 (3.1 %)

Enrolling by invitation

1 (0.4 %)

1 (0.7 %)

0 (0 %)

  1. aPercentage of total number per column
  2. bBrachytherapy in focus
  3. cOther trials
  4. * p value for availability of data between groups
  5. ** p value for test between BF and OT (without unavilable data)